A Realistic Case Confirming the Significance of Clinical Pharmacist Role Inside Community Pharmacies
Abstract
Diclofenac and ketorolac are prescribed as nonsteroidal anti-inflammatory drugs (NSAIDs) used to manage pain and inflammation. However, co-administration of them could lead to serious health problems. We seek to highlight the potential dangers of their concurrent use. We discuss the increased risk of severe gastrointestinal complications, including ulceration, bleeding, and perforation, associated with combining these medications. The case emphasizes the importance of clinician awareness of this drug interaction and advocates for safer prescribing practices. Also, we shed light on the significant role of clinical pharmacists in each community pharmacy, hospital, and medical centre.
2. Moore RA, McQuay HJ, Derry P, et al. Single dose oral diclofenac for acute postoperative pain in adults. Cochrane Database Syst Rev. 2004(2):CD004768.
3. Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin. 2010;26(7):1715–31.
4. Flores Murrieta FJ, Granados Soto V. Pharmacologic properties of ketorolac tromethamine: A potent analgesic drug. CNS Drug Reviews 1996; 2: 75-90
5. Catapano MS. The analgesic efficacy of ketorolac for acute pain. J Emerg Med. 1996;14(1):67-75.
Files | ||
Issue | Vol 12, No 3 (Summer 2024) | |
Section | Editorial | |
DOI | https://doi.org/10.18502/jpc.v12i3.16768 | |
Keywords | ||
clinical pharmacy community pharmacy Diclofenac Ketorolac |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |